In addition to genetic predispositions, variability in TC and TG concentration results from physical activity, diet, including carbohydrate and alcohol content, and smoking
2.1.9 D-2570 D-2570 is a novel oral TYK2 inhibitor being developed for autoimmune diseases including psoriasis and UC evaluated in a Phase 2 multicenter double-blind, placebo-controlled RCT (NCT07035041) with 120 participants randomized 1:1:1 to two different D-2570 dosing arms or placebo for 12 weeks
2 FIB levels were significantly lower after 8 weeks
LZ: Funding acquisition, Supervision, Validation, Writing review and editing
Some people have even reported severe GI-related issues, including gastroparesis, a paralysis of the stomach also called delayed gastric emptying
Juno Pharmaceuticals is a Canada-based pharmaceutical company that focuses on bringing complex and high-value generic and biosimilar products to the market